尔康制药：2025年度业绩预告

Core Viewpoint - The company Erkang Pharmaceutical (300267) expects a significant net loss for 2025, projecting a loss between 325 million to 385 million yuan, compared to a loss of 373.37 million yuan in the same period last year [1]. Financial Performance - The projected net loss for 2025 is estimated to be between 325 million yuan and 385 million yuan [1]. - The previous year's loss was reported at 373.37 million yuan [1].